Par Drugs (India) Probability of Future Stock Price Finishing Under 283.97

PAR Stock   229.40  6.00  2.55%   
Par Drugs' future price is the expected price of Par Drugs instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Par Drugs And performance during a given time horizon utilizing its historical volatility. Check out Par Drugs Backtesting, Par Drugs Valuation, Par Drugs Correlation, Par Drugs Hype Analysis, Par Drugs Volatility, Par Drugs History as well as Par Drugs Performance.
  
Please specify Par Drugs' target price for which you would like Par Drugs odds to be computed.

Par Drugs Target Price Odds to finish below 283.97

The tendency of Par Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under  283.97  after 90 days
 229.40 90 days 283.97 
about 80.01
Based on a normal probability distribution, the odds of Par Drugs to stay under  283.97  after 90 days from now is about 80.01 (This Par Drugs And probability density function shows the probability of Par Stock to fall within a particular range of prices over 90 days) . Probability of Par Drugs And price to stay between its current price of  229.40  and  283.97  at the end of the 90-day period is about 64.93 .
Assuming the 90 days trading horizon Par Drugs And has a beta of -0.5 indicating as returns on the benchmark increase, returns on holding Par Drugs are expected to decrease at a much lower rate. During a bear market, however, Par Drugs And is likely to outperform the market. Additionally Par Drugs And has an alpha of 0.1676, implying that it can generate a 0.17 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Par Drugs Price Density   
       Price  

Predictive Modules for Par Drugs

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Par Drugs And. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
222.98229.00235.02
Details
Intrinsic
Valuation
LowRealHigh
209.85215.87252.34
Details
Naive
Forecast
LowNextHigh
217.37223.39229.41
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
221.70276.18330.65
Details

Par Drugs Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Par Drugs is not an exception. The market had few large corrections towards the Par Drugs' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Par Drugs And, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Par Drugs within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.17
β
Beta against Dow Jones-0.5
σ
Overall volatility
29.11
Ir
Information ratio -0.0006

Par Drugs Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Par Drugs for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Par Drugs And can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Par Drugs And generated a negative expected return over the last 90 days
Par Drugs And has high historical volatility and very poor performance
Par Drugs And is unlikely to experience financial distress in the next 2 years
Latest headline from news.google.com: Stock market update Nifty Pharma index 1.03 percent in a weak market - MSN

Par Drugs Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Par Stock often depends not only on the future outlook of the current and potential Par Drugs' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Par Drugs' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding12.3 M
Cash And Short Term Investments366.5 M

Par Drugs Technical Analysis

Par Drugs' future price can be derived by breaking down and analyzing its technical indicators over time. Par Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Par Drugs And. In general, you should focus on analyzing Par Stock price patterns and their correlations with different microeconomic environments and drivers.

Par Drugs Predictive Forecast Models

Par Drugs' time-series forecasting models is one of many Par Drugs' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Par Drugs' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Par Drugs And

Checking the ongoing alerts about Par Drugs for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Par Drugs And help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Par Drugs And generated a negative expected return over the last 90 days
Par Drugs And has high historical volatility and very poor performance
Par Drugs And is unlikely to experience financial distress in the next 2 years
Latest headline from news.google.com: Stock market update Nifty Pharma index 1.03 percent in a weak market - MSN

Other Information on Investing in Par Stock

Par Drugs financial ratios help investors to determine whether Par Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Par with respect to the benefits of owning Par Drugs security.